Article info

PDF

Extended report
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

Authors

  1. Correspondence to Dr Gerd-Rűdiger Burmester, Department of Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Charitéplatz 1, Berlin 10117, Germany; gerd.burmester{at}charite.de
View Full Text

Citation

Burmester G, Kivitz AJ, Kupper H, et al
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

Publication history

  • Received October 16, 2013
  • Revised January 20, 2014
  • Accepted January 24, 2014
  • First published February 18, 2014.
Online issue publication 
May 08, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.